News & Updates
The American Cancer Society:
Relay-For-Life Funding Raising Event.
The American Cancer Society directs less than 3% of all funds raised to childhood cancers. So what does that mean to you? Why should you care?
Let's imagine that you participate in a Relay-For-Life with the intentions of raising money specifically for childhood cancer. Your team raises $2,000. Out of that money 10% or $200 will go to the American Cancer Society for administration costs. Their fundraising expenses are 18%, or $360. Out of the remaining $1,440, only 2.96% or less than $43 of the original $2,000 that you raised will go towards childhood cancer.
The moral of the story, be sure you know where your money goes, -- before you donate!
Source of information: Wikipedia, Pac-2, AIP, Google
Cancer Lab Grows to 14:
January 14, 2010
Mark Neidig, executive director of the Kanzius Cancer Research Foundation, just returned from several days of meetings and observation with Dr. Steven A. Curley, lead investigator at the Kanzius RF Laboratory at The University of Texas MD Anderson Cancer Center in Houston.
The impressive Kanzius RF Labs are now staffed with a team of 14 industry experts. An additional two post-doctorate positions will be filled soon, and a search for yet another PhD specializing in molecular biology and cancer cell targeting is under way. State and Federal grants along with generous individual donations to the Kanzius Cancer Research Foundation have made the progress of the past twelve months possible.
Cancer Rates Increase:
May 2, 2009
Over the next 20 years, the number of new cancer cases diagnosed annually in the United States will increase by 45 percent, from 1.6 million in 2010 to 2.3 million in 2030, with a dramatic spike in incidence predicted in the elderly and minority populations, according to a study published April 29 in Journal of Clinical Oncology.
Senate Passes Resolution:
Senator Hillary Rodham Clinton (D-NY)
Senators Wayne Allard (R-Colo.)
May 23, 2008
WASHINGTON, D.C.– September 13, 2008 will now be recognized as "National Childhood Cancer Awareness Day" as a result of a Senate resolution introduced by U.S. Senators Wayne Allard and Hillary Rodham Clinton (D-NY).
"Never before in history has the dream of eliminating childhood cancer been so attainable, yet seemed so elusive," said Senator Allard. "We live in a nation where the effectiveness of treatments and technology offer hope to children who dream of a bright future. Each case of childhood cancer is a very personal tragedy that can strike any family with children, at anytime, anywhere. In setting aside September 13th to recognize this battle on cancer, we continue of our efforts to draw attention to the victims of childhood cancer and the great work of the families and organizations who continue the fight."
"We have made tremendous strides in the fight against childhood cancer, but far too many children still suffer and lose their lives to this illness. The more we know as a nation the better able we will be to prevent and treat the disease and help those who are battling and surviving pediatric cancers. National Childhood Cancer Awareness Day is an opportunity to reach out to all Americans with the facts about childhood cancer, and this day will be an important symbol of our commitment on all days to find a cure," said Senator Clinton.
Talks began in Washington:
Dr. Steven Curley reports work is progressing at a rapid pace to take the John Kanzius Radio Frequency Cancer Treatment to the next step.
New targeting antibodies for human liver, pancreas, prostate, breast and colorectal cancers are being studied at this time, in addition to two new antibodies for leukemia.
Preliminary talks with the FDA began in February 2009 in Washington, DC and Dr. Curley will meet again with federal officials in early May to began work on a timeline for human clinical trials.
In support of fundraising activities, Dr. Curley spoke at two recent events in Florida, and plans are underway for an August/September symposium in Erie, Pennsylvania.
$500,000 Grant:
December 14th, 2009
State Representative John Hornaman represented Governor Edward G. Rendell in announcing a Department of Community and Economic Development grant of $500,000 to benefit the dream of the late broadcast executive John Kanzius to develop a device to stop cancer in its tracks.
The grant will be shared by the Kanzius Cancer Research Foundation, and Industrial Sales & Manufacturing of Erie, which is designing and producing the prototype human-sized scanner beds for human trials.
This grant will fortify the vision and hope of John Kanzius. "His invention has the potential to be the greatest cancer break-through in the last half-century,” Hornaman remarked.
John Kanzius Dies, Feb. 18, 2009
John Kanzius, who had no medical background but invented a device that kills cancer cells, has died at age 64.
Kanzius died Wednesday at the "Lee Memorial Health Park Medical Center" near Sanibel, Florida, where he had a winter home. The cause of death was pneumonia, a complication from two rounds of chemotherapy he had recently undergone.
The Kanzius Cancer Research Foundation regretfully announces the passing of John Kanzius on Wednesday, February 18, 2009. John’s passing, at a hospital near his winter home in Sanibel, Florida, has come at a time when his cancer invention was entering the final stages of animal testing and nearing the time when it would become available for human clinical trials.
“We will not stop until John’s vision becomes reality,” said Maryann Yochim, president of the Kanzius Cancer Research Foundation. “Our only regret at this point is that John will not be here to see the first cancer patient cured with his technology. But, we believe strongly that this will happen. It’s only a matter of time.”
Lead researcher, Steven Curley, MD will continue his work at a lab at the M.D. Anderson Cancer Center, which is dedicated specifically to John’s invention. Your donations have helped to increase the number of researchers working on this project and will continue to provide the funds necessary to see it to completion. We remain committed to John’s mission to find a cure for cancer.
Dr. Steven Curley Reacts:
The research with the Kanzius radiofrequency/nanoparticle treatment for cancer will continue and John will get the full honor and credit he deserves for his energy, industry, and ingenuity. The great people of Erie and Sanibel/Fort Myers have allowed us to make progress much more rapidly then we could have done without their support, and I will honor my commitment to both places to include them in early human clinical trials. John's legacy must and will live on. I will continue this important research work with renewed vigor and focus because I despise this disease that has stolen another brilliant individual from us.
Posted Friday, February 20th
Article from the Naples Daily News by Matt Clark
Edited for content: K.I.D. Cancer Foundation